TL;DR: The AdvisorShares Pure US Cannabis ETF (MSOS) closed Monday at $4.36, down 4.39% on below-average volume, as the sector entered pre-earnings consolidation mode. After-hours recovery of +0.66% to $4.39 signals institutional reaccumulation ahead of the Q2 reporting window, which opens with Tilray Brands (TLRY) on July 28 and extends through the first week of August for the major U.S. multi-state operators.
Monday Market Recap: Controlled Selling Below Average Volume
Monday’s cannabis sector session was defined by measured selling pressure across the MSOS complex. The benchmark ETF opened at $4.52 before declining through the session, touching an intraday low of $4.33 before settling at $4.36 — a 4.39% decline from Friday’s $4.56 close. Volume of 6.88 million shares came in 24.7% below the 90-day average of 9.15 million, a reading that materially changes the interpretation of the decline: this was systematic repositioning, not liquidation.
Tilray Brands (TLRY), which reports Q4 FY2026 results on July 28 — exactly eight days from Monday’s close — led individual-name weakness, declining 1.63% to $4.23 and testing a fresh 52-week low of $4.195 intraday. The 52-week range of $4.195–$23.20 frames the extent of TLRY’s prolonged compression, but Monday’s after-hours recovery to $4.26 (+0.82%) suggests that at current levels, downside-risk premium may be adequately reflected in the price. Q3 FY2026 revenue of $206.73 million sets the baseline against which Tuesday’s macro read on the stock will be benchmarked ahead of the July 28 print.
Green Thumb Industries (GTBIF), the sector’s standout profitable large-cap MSO, traded in a $7.51–$7.79 intraday range. With Q1 FY2026 revenue of $300.19 million, a trailing P/E of 14.90, and $121.24 million in TTM net income, GTBIF remains the benchmark for MSO profitability as peers continue to operate near breakeven or in the red. The consensus analyst target of $15.67 represents a 106% upside from Monday’s settlement, reinforcing the structural valuation disconnect that has characterized the sector throughout 2025–2026.
Q2 Earnings Calendar: A Nine-Day Catalyst Window Beginning July 28
The earnings calendar that opens July 28 represents the most concentrated near-term catalyst cluster the cannabis sector faces in 2026. Four of the largest names — representing a combined market capitalization of approximately $5.3 billion at current prices — report within a nine-day window:
- Tilray Brands (TLRY) — July 28
- Green Thumb Industries (GTBIF) — August 4
- Curaleaf Holdings (CURLF) — August 5
- Trulieve Cannabis (TCNNF) — August 6
Curaleaf (CURLF), the sector’s largest operator by revenue at $1.29 billion TTM, carries a $2.51 billion market cap and posted a 158.47% one-year return through recent trading. Despite remaining net-unprofitable, levered free cash flow of $82.49 million signals that the company is generating meaningful operating cash even as accounting losses persist — a distinction that Q2 narrative framing will need to address for the stock to sustain its 2026 recovery.
Trulieve (TCNNF), the dominant Florida-market MSO, posted $286.8 million in Q1 FY2026 revenue and carries an enterprise value-to-EBITDA of 5.79 at recent prices — the most value-oriented multiple among large-cap MSOs. With a consensus analyst target of $19.42 and an August 6 reporting date, TCNNF presents a high-conviction setup for investors who believe Florida’s structural retail demand trajectory remains durable despite the 2024 adult-use ballot outcome.
Market Context and Positioning Framework for Tuesday
MSOS has returned 74.05% over the trailing 12 months despite a -3.39% YTD drawdown — a divergence that reflects the sector’s sensitivity to macro risk-off episodes and regulatory calendar uncertainty. The Schedule III rescheduling administrative proceeding continues without a confirmed hearing date for the remainder of 2026, but the practical impact of that outcome has increasingly been subordinated to the quarterly earnings narrative as institutional attention pivots to near-term fundamental inflection.
The institutional signal embedded in Monday’s session is conditionally constructive: below-average volume on a broad decline, followed by after-hours recovery across TLRY (+0.82%) and MSOS (+0.66%), is consistent with pre-earnings compression rather than trend reversal. The pattern rewards investors who position into weakness during the consolidation phase rather than chasing post-earnings volatility.
Tuesday’s session should serve as a continuation read. If MSOS recaptures the $4.45–$4.50 range, Monday’s decline will be classified as noise within an intact pre-earnings setup. A second consecutive close below $4.36 would shift the probability-weighted read toward a more significant pre-reporting rotation. Track real-time price action on all major names at the cannabis stock tracker as the nine-day window to Tilray’s July 28 earnings begins to close.